Short description
MicrobiotiX develops therapies for unmet needs, multidrug-resistant infections, metabolic diseases, and auto-immune diseases.
Description
MicrobiotiX is a developer of bacteriophage-based treatments for multidrug-resistant bacteria, microbiome-based treatments using microbiota banking, and treatments related to autoimmune diseases and other untreatable diseases. It serves to utilize safe gastrointestinal microbiota transplants in a medical environment and formulate capsules for oral administration.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Seoul, Seoul-t'ukpyolsi, South Korea, Asia
Founded on
January 1, 2016
Non-profit?
No
Acquired?
No
Employees count
11-50
Founders
Dongeun Yong